Verzögert
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
1.4 SEK | -96.26% | -.--% | -22.82% |
21.05. | Immunovia strebt 70 Millionen SEK aus geplantem Bezugsrechtsangebot an | MT |
29.04. | Transcript : Immunovia AB, Q1 2024 Earnings Call, Apr 29, 2024 |
Performance
1 Tag | -96.26% | ||
3 Monate | -27.79% | ||
6 Monate | -42.62% | ||
Laufendes Jahr | -22.82% | ||
1 Jahr | -27.84% | ||
3 Jahre | -98.51% | ||
5 Jahre | -99.27% |
Volumen
MärkteBasisdaten
Extremkurse
Indikatoren
Sektorenvergleich - Medizinische Diagnose- und Prüfgeräte
Name | % | % 5 Tage | % 1. Jan. | % 1 Jahr | Kap. | |
---|---|---|---|---|---|---|
-96.26% | -.--% | -22.82% | -27.84% | 6.02 Mio. | ||
-0.59% | -6.69% | -24.25% | -21.35% | 17.05 Mrd. | ||
+1.31% | +0.02% | -42.47% | -50.43% | 2.84 Mrd. | ||
+3.18% | -4.64% | +17.00% | +69.60% | 1.85 Mrd. | ||
+4.43% | -4.75% | -6.24% | +6.04% | 1.56 Mrd. | ||
+4.19% | +5.35% | +38.44% | +29.53% | 1.36 Mrd. | ||
+1.45% | -2.97% | -19.86% | -28.21% | 924 Mio. | ||
+0.78% | -3.80% | -25.21% | -37.58% | 856 Mio. | ||
-0.79% | +3.71% | +7.00% | -7.39% | 841 Mio. | ||
+0.75% | -1.47% | -27.85% | -32.03% | 604 Mio. | ||
+0.10% | -3.59% | +20.28% | +30.77% | 573 Mio. | ||
+2.65% | -.--% | -.--% | -.--% | 484 Mio. | ||
+2.69% | -3.45% | -18.10% | +43.50% | 271 Mio. | ||
-1.37% | -5.40% | -42.25% | -28.87% | 223 Mio. | ||
+1.36% | -1.74% | +9.29% | +71.20% | 120 Mio. | ||
-2.03% | +3.86% | -26.51% | -25.65% | 112 Mio. | ||
Durchschnitt | -4.90% | -2.64% | -10.22% | -0.54% | ||
Gewichteter Durchschnitt nach Marktkapitalisierung | +0.51% | -4.39% | -17.38% | -12.94% |
Historische Daten
Datum | Eröffnung | Hoch | Tief | Schlusskurs | Volumen |
---|
Monatliche Veränderungen
Jährliche Veränderungen
2024 | -22.82% | ||
2023 | -93.12% | ||
2022 | -63.26% | ||
2021 | -40.70% | ||
2020 | -32.17% | ||
2019 | -6.79% | ||
2018 | +96.31% |
- Börse
- Aktien
- A2AG0F Aktie
- A2AG0F Aktie
- Kurse Immunovia AB